Austria vs Monaco: Life science patents granted, by technology
Austria
2 patents
in 2023
Monaco
1 patents
in 2020
Austria rank
51st
Monaco rank
54th
Life science patents granted, by technology over time
- Austria
- Monaco
How they compare
Austria currently reports 2 patents against 1 patents in Monaco, a difference of 1 patents.
That makes Austria's figure about 2.0 times Monaco's.
The two have swapped places 1 time across 29 shared years of data; in 1980 it was Austria ahead.
Austria ranks 51st and Monaco ranks 54th of 64 countries.
Austria has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Austria | Monaco | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 119.4 patents | 11.2 patents | 108.2 patents | Austria |
| 1990s | 43.25 patents | 6.12 patents | 37.12 patents | Austria |
| 2000s | 15 patents | 1.6 patents | 13.4 patents | Austria |
| 2010s | 6 patents | 1.2 patents | 4.8 patents | Austria |
| 2020s | 1 patents | 1 patents | 0 patents | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by technology, Austria or Monaco?
- Austria, at 2 patents against 1 patents in Monaco as of 2023.
- What is the difference in life science patents granted, by technology between Austria and Monaco?
- 1 patents, with Austria ahead.
- How many years of comparable data are there for Austria and Monaco?
- 29 years are reported by both, from 1980 to 2020.
- How do Austria and Monaco rank globally for life science patents granted, by technology?
- Austria ranks 51st and Monaco ranks 54th of 64 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) – processed by Our World in Data, published as Life science patents granted, by technology. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of pharmaceutical patents granted by the filing office in a given year. Pharmaceutical patents typically cover new drugs, biological treatments or vaccines.